To assess the role of medication through rectal route in oligizoospermia

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF ARDHMATRIK AND VIDARIKANDADI KALA BASTI IN MALE INFERTILITY DUE TO KSHEEN SHUKRA (OLIGOZOOSPERMIA) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056533

Enrollment

Registered

2023-08-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N468- Other male infertility

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male patients of age between 21 and 40. 2. Patients with Oligozoospermia, i.e, low sperm count and motility of sperm.

Exclusion criteria

Exclusion criteria: 1. Patients with any systemic disease interfering in the course of treatment. 2. Varicocele, Endocrine disorders, STD, or any trauma. 3. Patients who are unfit for Basti

Design outcomes

Primary

Measure	Time frame
Complete Remission: 100% relief. Marked Improvement: 75% relief to 99 % relief. Moderate Improvement: 50 % to 74 % relief. Mild Improvement: 25% to 49% relief. No Improvement: up to 24% relief.Timepoint: 8 Weeks	—

Secondary

Measure	Time frame
Complete Remission: 100% relief. Marked Improvement: 75% relief to 99 % relief. Moderate Improvement: 50 % to 74 % relief. Mild Improvement: 25% to 49% relief. No Improvement: up to 24% relief.Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr. Parmod Kumar

Himalayiya Ayurvedic PG Medical College And Hospital

prmdkmbj00@gmail.com7015302830

Outcome results